These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17475864)

  • 1. Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent.
    Ramsburg EA; Publicover JM; Coppock D; Rose JK
    J Immunol; 2007 May; 178(10):6350-8. PubMed ID: 17475864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins.
    Haglund K; Leiner I; Kerksiek K; Buonocore L; Pamer E; Rose JK
    J Virol; 2002 Aug; 76(15):7506-17. PubMed ID: 12097563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.
    Publicover J; Ramsburg E; Rose JK
    J Virol; 2005 Nov; 79(21):13231-8. PubMed ID: 16227246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses.
    Haglund K; Leiner I; Kerksiek K; Buonocore L; Pamer E; Rose JK
    J Virol; 2002 Mar; 76(6):2730-8. PubMed ID: 11861840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.
    Andreasen SO; Christensen JE; Marker O; Thomsen AR
    J Immunol; 2000 Apr; 164(7):3689-97. PubMed ID: 10725727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.
    Bolesta E; Kowalczyk A; Wierzbicki A; Eppolito C; Kaneko Y; Takiguchi M; Stamatatos L; Shrikant PA; Kozbor D
    J Immunol; 2006 Jul; 177(1):177-91. PubMed ID: 16785513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants.
    Gonzalo RM; Rodríguez D; García-Sastre A; Rodríguez JR; Palese P; Esteban M
    Vaccine; 1999 Feb; 17(7-8):887-92. PubMed ID: 10067695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.
    Burkhart C; Freer G; Castro R; Adorini L; Wiesmüller KH; Zinkernagel RM; Hengartner H
    J Virol; 1994 Mar; 68(3):1573-80. PubMed ID: 7508998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.
    Sauzet JP; Gras-Masse H; Guillet JG; Gomard E
    Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals.
    Granelli-Piperno A; Zhong L; Haslett P; Jacobson J; Steinman RM
    J Immunol; 2000 Dec; 165(11):6620-6. PubMed ID: 11086107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help.
    Burkhart C; Freer G; Steinhoff U; Li Y; Bishop DH; Zinkernagel RM; Hengartner H
    Viral Immunol; 1994; 7(3):103-11. PubMed ID: 7541205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells.
    Schluns KS; Williams K; Ma A; Zheng XX; Lefrançois L
    J Immunol; 2002 May; 168(10):4827-31. PubMed ID: 11994430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells.
    Badovinac VP; Messingham KA; Griffith TS; Harty JT
    J Immunol; 2006 Jul; 177(2):999-1006. PubMed ID: 16818756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for CD4 T cell help in generating functional CD8 T cell memory.
    Shedlock DJ; Shen H
    Science; 2003 Apr; 300(5617):337-9. PubMed ID: 12690201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 T cell-dependent CD8 T cell maturation.
    Khanolkar A; Fuller MJ; Zajac AJ
    J Immunol; 2004 Mar; 172(5):2834-44. PubMed ID: 14978084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
    Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activity.
    Brown SA; Stambas J; Zhan X; Slobod KS; Coleclough C; Zirkel A; Surman S; White SW; Doherty PC; Hurwitz JL
    J Immunol; 2003 Oct; 171(8):4140-8. PubMed ID: 14530336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.